NCT06360588 2026-04-17
Testing Copanlisib as Potentially Targeting Treatment in Cancers With PTEN Loss (MATCH - Subprotocol Z1G)
National Cancer Institute (NCI)
Phase 2 Active not recruiting
National Cancer Institute (NCI)
SWOG Cancer Research Network
SWOG Cancer Research Network
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Roswell Park Cancer Institute
Eastern Cooperative Oncology Group
Mayo Clinic
Mayo Clinic
NRG Oncology
Fred Hutchinson Cancer Center
SWOG Cancer Research Network
Mayo Clinic
Mayo Clinic
Thomas Jefferson University